(3R)-N-[3-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-4-methylphenyl]-3-hydroxypyrrolidine-1-carboxamide
C25H26N4O3 — CID 71115889
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R)-N-[3-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-4-methylphenyl]-3-hydroxypyrrolidine-1-carboxamide
(3R)-N-[3-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-4-methylphenyl]-3-hydroxypyrrolidine-1-carboxamide (PubChem CID 71115889) has the molecular formula C25H26N4O3 and a molecular weight of 430.51 g/mol. Its IUPAC name is (3R)-N-[3-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-4-methylphenyl]-3-hydroxypyrrolidine-1-carboxamide.
Molecular Properties
| Compound Name | (3R)-N-[3-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-4-methylphenyl]-3-hydroxypyrrolidine-1-carboxamide |
|---|---|
| PubChem CID | 71115889 |
| Molecular Formula | C25H26N4O3 |
| Molecular Weight | 430.51 g/mol |
| Exact Mass | 430.20 |
| IUPAC Name | (3R)-N-[3-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-4-methylphenyl]-3-hydroxypyrrolidine-1-carboxamide |
| SMILES | Cc1ccc(NC(=O)N2CC[C@@H](O)C2)cc1-c1ccc2cc(NC(=O)C3CC3)ncc2c1 |
| InChI | InChI=1S/C25H26N4O3/c1-15-2-7-20(27-25(32)29-9-8-21(30)14-29)12-22(15)18-6-5-17-11-23(26-13-19(17)10-18)28-24(31)16-3-4-16/h2,5-7,10-13,16,21,30H,3-4,8-9,14H2,1H3,(H,27,32)(H,26,28,31)/t21-/m1/s1 |
| InChIKey | BUSXOZOSXGTNSE-OAQYLSRUSA-N |
| XLogP | 4.16 |
| TPSA | 94.56 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 430.51 |
| LogP ≤ 5 | 4.16 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71115889 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.